- 1Department of Tissue and Embryology, School of Basic Medical Sciences, Wuhan University, Wuhan, China
- 2Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China
- 3Reproductive Medicine Center, Department of Obstetrics and Gynecology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
- 4Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China
- 5Center for Reproduction and Genetics, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- 6State Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, China
SYMPK is a scaffold protein that supports polyadenylation machinery assembly on nascent transcripts and is also involved in alternative splicing in some mammalian somatic cells. However, the role of SYMPK in germ cells remains unknown. Here, we report that SYMPK is highly expressed in male germ cells, and germ cell-specific knockout (cKO) of Sympk in mouse leads to male infertility. Sympk cKODdx4–cre mice showed reduced spermatogonia at P4 and almost no germ cells at P18. Sympk cKOStra8–Cre spermatocytes exhibit defects in homologous chromosome synapsis, DNA double-strand break (DSB) repair, and meiotic recombination. RNA-Seq analyses reveal that SYMPK is associated with alternative splicing, besides regulating the expressions of many genes in spermatogenic cells. Importantly, Sympk deletion results in abnormal alternative splicing and a decreased expression of Sun1. Taken together, our results demonstrate that SYMPK is pivotal for meiotic progression by regulating pre-mRNA alternative splicing in male germ cells.
Introduction
Mammalian spermatogenesis is a continuous, well-organized process of germ cell differentiation including mitosis in spermatogonia, meiosis in spermatocyte, and spermiogenesis (Griswold, 2016). During this process, the gene expression pattern is highly dynamic and under precise control, which owes partly to alternative splicing (AS) and the polyadenylation modification of messenger RNAs (mRNAs) (Kashiwabara et al., 2002; Kan et al., 2005; Goldstrohm and Wickens, 2008; Weill et al., 2012). Additionally, several regulators of pre-mRNA splicing are primarily or specifically expressed in the testis (Schmid et al., 2013).
Previous studies have shown that there were abundant AS variants in spermatogenic cells (Yeo et al., 2004; Schmid et al., 2013; Margolin et al., 2014). Of note is that exon–exon junction (EEJ) and intron retention (IR) are the major AS modes in male germ cells (Chen et al., 2018). Recently, increasing evidences support the idea that AS plays an important role in mouse spermatogenesis. For example, PTBP2, which is required for the AS regulation of germ cell mRNAs, is critical for male germ cell survival and fertility (Zagore et al., 2015; Hannigan et al., 2017). In addition, many other RNA-binding proteins, such as RBM5 (O’Bryan et al., 2013), RANBP9 (Bao et al., 2014), BCAS2 (Liu et al., 2017), and the m6A reader YTHDC1 (Kasowitz et al., 2018), are also involved in modulating AS during meiosis and are indispensable for germ cell survival and mouse fertility.
SYMPK was initially identified as a protein associated with the tight junctions of polarized epithelial cells (Keon et al., 1996). The interaction of SYMPK with cleavage and polyadenylation and specificity factors (CPSFs) and cleavage stimulation factor F (CSTF) suggests its function in the assembly of the polyadenylation machinery (Takagaki and Manley, 2000; Hofmann et al., 2002). Further study confirmed that SYMPK is indeed necessary for nuclear polyadenylation (Xing et al., 2004) and cytoplasmic polyadenylation element-binding protein (CPEB)-mediated cytoplasmic polyadenylation in Xenopus oocytes (Barnard et al., 2004). In tumor cells, SYMPK is required for mitotic fidelity by supporting microtubule dynamics (Cappell et al., 2010). Importantly, SYMPK has been identified as a cofactor of RBFOX2 and NOVA2 to regulate alternative mRNA splicing (Misra et al., 2015). Recently, it has been reported that SYMPK promotes the self-renewal and pluripotency of embryonic stem cells (ESCs) through interaction with OCT4 (Yu et al., 2019). Nevertheless, the function of SYMPK in male germ cells is still unclear.
Here, we report that SYMPK is highly expressed in the testes and is indispensable for meiosis progression and mouse fertility. Disruption of Sympk leads to the dysregulation of transcription and AS in spermatogenic cells. Our data reveal the essential role of SYMPK in meiosis and male fertility.
Results
SYMPK Is Highly Expressed in Mouse Testes
To explore the potential function of SYMPK in mouse spermatogenesis, we firstly determined the expression level of SYMPK in different mouse tissues by immunoblotting with an anti-SYMPK antibody. SYMPK abundance was much higher in the testes compared with other tissues (Figure 1A). Immunostaining was then used to determine the subcellular localization of SYMPK in mouse testes. In newborn mouse testes (postnatal day 1, P1), SYMPK was highly expressed in the prospermatogonia located in the middle of the seminiferous tubules (Figure 1B). At P4 and P13, SYMPK expression was relatively high in a subset of cells located close to the basement membrane, which are presumably spermatogonia (Figure 1B). Co-immunostaining of SYMPK and the spermatogonia-specific transcription factor PLZF confirmed that SYMPK was highly enriched in spermatogonia in P12 testes (Figure 1C). In adult testes, SYMPK was abundantly enriched in spermatogonia, spermatocytes, round spermatids, and elongated spermatids in stages IV–VI and XII of seminiferous tubules (Figures 1D,E). These data suggest that SYMPK probably plays important roles in the entire process of spermatogenesis.
Figure 1. SYMPK is abundantly expressed in mouse testes. (A) Immunoblot analysis of SYMPK expression in different tissues from adult mouse. GAPDH was used as the loading control. (B) Immunostaining of SYMPK in mouse testes at postnatal day 1 (P1), P4, and P13. Scale bar, 20 μm. (C) Frozen sections of P12 testes were co-stained with rabbit anti-SYMPK and mouse anti-PLZF antibodies. DNA was stained with DAPI. Scale bar, 50 μm. (D,E) Immunofluorescence analysis of SYMPK in adult testes. SYMPK (green) and acrosome marked by PNA (red). Scale bar, 50 μm.
SYMPK Is Essential for Male Fertility
To investigate the physiological function of SYMPK in mouse fertility, SympkFlox/+ mice were obtained and used for generating the SympkFlox/Flox (SympkF/F) mouse line, which allowed us to inactivate Sympk by deleting exons 4 and 5 in a cell- or tissue-specific manner using Cre recombinases (Figure 2A). It has been well established that Cre is active in the germ cells of Ddx4-Cre mice at embryonic day 15 (Gallardo et al., 2007) in the spermatogonia of Stra8-Cre mice at 3 days postpartum (Sadate-Ngatchou et al., 2008). The immunostaining experiments found that SYMPK was absent in germ cells from the testes of Sympk cKODdx4–Cre and Sympk cKOStra8–Cre mice at P4 and P13, respectively (Supplementary Figure 1).
Figure 2. SYMPK is essential for male fertility. (A) Schematic diagram of the targeting strategy for the generation of SympkF/F and Sympk cell-specific knockout (cKO) mice. Exons 4 and 5 were flanked by loxP and will be deleted by Cre recombinase. The positions of the primers used for genotyping are shown as arrows. (B,C) Morphological analysis (B) and testis weight (C) of adult control and Sympk cKOStra8–Cre mice (***p < 0.001, n = 3). (D) Histology of testes from wild-type control and Sympk cKOStra8–Cre mice at P10 and P16. (E) Apoptosis of wild-type control and Sympk cKOStra8–Cre seminiferous tubules at P18 was analyzed with the TUNEL assay. Scale bar, 50 μm. (F) Histology of the testes and cauda epididymides from adult wild-type control and Sympk cKOStra8–Cre mice.
Sympk cell-specific knockout (cKO) male mice were viable and grossly normal. However, both the Sympk cKODdx4–Cre and Sympk cKOStra8–Cre male mice were infertile. The testes of adult Sympk cKOStra8–Cre male mice were much smaller than those of the wild-type (wt) mice, with significantly reduced testis weight (Figures 2B,C). Similarly, testes from Sympk cKODdx4–Cre males were also much smaller than those from wt mice (Supplementary Figure 2A). Histological analysis revealed that there was no apparent difference in the germ cell numbers in the seminiferous tubules between the wt control and Sympk cKOStra8–Cre mice at P10 (Figure 2D), while the number of germ cells was sharply reduced in Sympk cKODdx4–Cre testes as early as P10 (Supplementary Figure 2B). Noticeably, the number of spermatocytes in Sympk cKOStra8–Cre tubules was significantly reduced compared with those in wt mice at P16 (Figure 2D). By TdT-mediated dUTP nick-end labeling (TUNEL) assays, increasing Sympk-deficient spermatocytes were positive for TUNEL labeling, which suggests that they were undergoing apoptosis (Figure 2E). The testes from adult Sympk cKOStra8–Cre males (Figure 2F) lacked post-meiotic spermatids, and the most advanced germ cells were spermatocytes, suggesting meiotic defects. Expectedly, no sperm was observed in the epididymis from adult Sympk cKOStra8–Cre males (Figure 2F). The testes and epididymis from adult Sympk cKODdx4–Cre males were completely devoid of germ cells and sperm, respectively (Supplementary Figure 2C). The above data demonstrate that SYMPK is required for male fertility.
To determine whether SYMPK deficiency would affect the survival of spermatogonia, testis sections were stained with an anti-PLZF antibody. We found that the number of PLZF-positive cells in Sympk cKOStra8–Cre testes was comparable to that in wt testes at P13 (Supplementary Figures 3A,B), which suggests that the deletion of Sympk after birth does not affect spermatogonial survival. However, the number of cells expressing SYCP3 in Sympk cKOStra8–Cre tubules was much less than that in wt testes at P13, and some Sympk cKOStra8–Cre tubules did not contain SYCP3-positive cells (Supplementary Figures 3C,D). DDX4 is a germ cell-specific marker. We stained the frozen sections of P4 and P18 testes with the DDX4 antibody and the numbers of DDX4-positive cells in each seminiferous tubule were counted. The results showed that the number of DDX4-positive cells sharply reduced in Sympk cKOStra8–Cre males at P18 (Supplementary Figure 3G). Interestingly, the number of DDX4-positive cells was reduced in Sympk cKODdx4–Cre males at P4 and disappeared at P18 (Supplementary Figures 3E–G), which suggest that deletion of Sympk at the embryonic stage has a negative influence on the survival of spermatogonia. Taken together, these results suggest that SYMPK was required for spermatogonial survival and meiosis in spermatocytes.
Sympk Deletion Causes Defects in Chromosome Synapsis and DSB Repair
To further determine the role of SYMPK in meiosis, we tested whether Sympk deficiency affects chromosome synapsis and DNA double-strand break (DSB) repair, which are critical for meiosis progression. Homologous chromosomal synapsis was assessed by immunostaining of spread nuclei using antibodies against SYCP1, a component of the synaptonemal complex (SC) transverse elements, and SYCP3, a component of SC axial elements (de Vries et al., 2005; Kogo et al., 2012). Chromosomes from the wt pachytene spermatocytes maintained faithful synapsis, whereas many of the Sympk cKOStra8–Cre pachytene-like spermatocytes showed defects or failure of chromosome synapsis, as characterized by the absence of full autosome synapsis and dissociation of the sex chromosome (Figure 3A). HORMAD1, associated with unsynapsed chromosome axes (Fukuda et al., 2010), was also used to evaluate the chromosome synapsis. In wild-type pachytene spermatocytes, HORMAD1 only localized in the unsynapsed sex chromosomes, but in the Sympk cKO spermatocytes, several unsynapsed autosomes are positive for HORMAD1 (Figure 3B). The result from HORMAD1 staining further confirmed the synapsis defects in Sympk cKO spermatocytes.
Figure 3. Failure of chromosome synapsis and double-strand break (DSB) repair in Sympk cKOStra8–Cre spermatocytes. (A) Chromosome spreads from wild-type (wt) control and Sympk cKOStra8–Cre testes were labeled for synaptonemal complex proteins (SYCP1 and SYCP3). Purple arrow shows the incomplete synapsis in the autosome of pachytene spermatocyte; white arrow shows the separation of the sex chromosome. (B) Spermatocytes from wt control and Sympk cKOStra8–Cre testes were immunostained for HORMAD1 and SYCP3. (C) Chromosome spreads from control and Sympk cKOStra8–Cre testes were immunostained for γH2AX and SYCP3. DNA was stained with DAPI. Scale bar, 20 μm. (D) Percentages of spermatocytes at different stages (leptotene to diplotene) from the testes of wt control and Sympk cKOStra8–Cre mice at P18. wt spermatocytes, 423; Sympk cKO spermatocytes, 339.
DSB formation and its repair were assessed using the DSB marker γH2AX, which is phosphorylated by the ATM and ATR kinases (Bellani et al., 2005). The γH2AX signal was distributed similarly between Sympk cKOStra8–Cre and wt spermatocytes at the leptonema and zygonema, indicating that SYMPK is not essential for DSB formation (Figure 3C). During the pachynema and diplonema, the γH2AX signal was restricted to the XY body in wt spermatocytes, while in Sympk cKOStra8–Cre spermatocytes, γH2AX also localized in some autosomes besides the XY body (Figure 3C), indicating that DSBs were not properly repaired in Sympk cKOStra8–Cre spermatocytes at the pachytene and diplotene stages. In addition, XY body formation was impaired in some Sympk-deficient spermatocytes (Figure 3A). These results suggest that Sympk deletion leads to failure of the DSB repair. In addition, we quantified the spermatocytes at different stages from juvenile wt and Sympk cKOStra8–Cre males at P18. The results showed that fewer Sympk cKOStra8–Cre spermatocytes can progress into the pachynema and diplonema when compared with the wt males (Figure 3D), suggesting that Sympk-deficient spermatocytes were mainly arrested at the pachytene stage.
Previous studies have suggested that BRCA1 recruits the ATR kinase to phosphorylate H2AX on unsynapsed chromosomes (Turner et al., 2004) and has a role in repairing DSBs (Xu et al., 2003). Given the failure of chromosome synapsis and DSB repair, we wondered whether the localization of BRCA1 is also affected in Sympk cKO spermatocytes. Therefore, BRCA1 localization was determined and compared between the wt and Sympk cKO spermatocytes. At the zygotene stage, BRCA1 accumulated on the unsynapsed axes of chromosomes in both wt and Sympk cKO spermatocytes. At the pachytene stage, BRCA1 was restricted in the sex chromosomes in wt spermatocytes, but persisted in the unsynapsed chromosomes in Sympk cKO pachytene spermatocytes (Supplementary Figure 4). The localization of BRCA1 is consistent with the defects in DSB repair and chromosome synapsis in Sympk cKO spermatocytes.
Deficiency of Sympk Impairs Meiotic Recombination and Crossover Formation
To determine whether SYMPK deficiency affects meiotic recombination, the recombination nodules were evaluated by immunostaining with RPA2, MEIOB, RAD51, and DMC1 on spread nuclei. RPA2 is a subunit of the RPA complex that binds to single-strand NA (ssDNA) (Ribeiro et al., 2016). MEIOB, an ssDNA-binding protein, is one of the most important meiotic prophase I regulators that are required for meiotic recombination through interactions with SPATA22 and RPA2 (Luo et al., 2013; Lascarez-Lagunas et al., 2020). DMC1 and RAD51 are involved in DNA strand invasion and exchange (Brown and Bishop, 2014). Consistent with the defects of DSB repair in Sympk cKOStra8–Cre pachytene spermatocytes, the numbers of RPA2 and MEIOB foci increased in Sympk cKOStra8–Cre pachytene spermatocytes (Figures 4A,B). Meanwhile, the numbers of DMC1 and RAD51 foci decreased significantly in Sympk cKOStra8–Cre zygotene-like and pachytene-like spermatocytes (Figures 4C,D). The above aberrant recombination nodules suggest that meiotic recombination was defective in Sympk cKO spermatocytes.
Figure 4. SYMPK is required for meiotic recombination. Chromosome spreads of spermatocytes from wild-type (wt) control and Sympk cKOStra8–Cre testes were labeled with RPA2, MEIOB, DMC1, RAD51, and SYCP3. Based on the staining pattern of the synaptonemal complex lateral element (SYCP3), the spermatocytes were classified into the following stages: leptotene (Le), zygotene (Zy), pachytene (Pa), zygotene-like (Zy-like), and pachytene-like (Pa-like). Each dot represents the number of DNA repair protein foci per cell. Solid lines show the average number of foci in each category of spermatocytes. Data were collected from three mice. (A) RPA2 foci. (B) MEIOB foci. (C) DMC1 foci. (D) RAD51 foci. Representative images of the spermatocytes at the zygotene, zygotene-like, pachytene, or pachytene-like stages are shown (A–D). Scale bar, 20 μm.
In order to determine the effect of Sympk deficiency on crossover formation, the MLH1 foci were visualized on pachytene chromosomes. We found that the average number of MLH1 foci was 25.1/cell in wt pachytene spermatocytes (Supplementary Figures 5A,B), which is similar to that in a previous report (Anderson et al., 1999). In contrast, the number of MLH1 foci reduced to as low as four per cell in Sympk cKOStra8–Cre pachytene-like spermatocytes (Supplementary Figures 5A,B).
Taken together, our results demonstrated that, in the absence of SYMPK, the early steps of meiotic recombination, such as DSB formation and DNA resection, progressed well, while the subsequent steps, such as strand invasion, chromosome synapsis, DSB repair, and crossover formation, were impaired, finally leading to meiotic failure.
SYMPK Interacts With DDX5 and PRPF8 in Spermatogenic Cells
SYMPK has been previously reported to regulate the AS in somatic cells (Flp-In-293 cells) (Misra et al., 2015). Considering that the testes contain high levels of AS events (Elliott and Grellscheid, 2006), we asked whether the function of SYMPK regulating AS was conserved in germ cells. Firstly, we performed an immunoprecipitation–mass spectrometry (IP-MS) assay using an antibody against SYMPK to identify the splicing factors interacting with SYMPK in spermatogenic cells. Spermatogenic cells were enriched from wt and Sympk cKOStra8–Cre testes and used to determine the protein expression. Enriched spermatogenic cells were determined by Western blotting (Supplementary Figure 6). Multiple proteins associated with pre-mRNA processing were detected in the IP-MS results of the SYMPK antibody pull-down products, including pre-mRNA processing factors, i.e., PRPF8 (pre-mRNA-processing-splicing factor 8), PRPF19, PRPF40a, WTAP (pre-mRNA-splicing regulator WTAP), and CWC22 (pre-mRNA-splicing factor CWC22 homolog), and two RNA helicases, DDX5 [DEAD (Asp-Glu-Ala-Asp) box helicase 5] and DHX15 (pre-mRNA-splicing factor ATP-dependent RNA DEAH-box helicase 15). PRPF8 and DDX5 are two enriched putative SYMPK-binding proteins based on the number of matched peptides in the wt and Sympk cKO groups (Supplementary Table 3). These two proteins were chosen for further analysis. In both P16 and adult mouse testes, PRPF8 and DDX5 localized in the nucleus of spermatogenic cells, but not in elongated spermatids (Figures 5A,B). Due to the lack of suitable antibodies, the co-localization between PRPF8, DDX5, and SYMPK was not determined. Using in vivo co-immunoprecipitation assays, we confirmed that DDX5 and PRPF8 indeed interacted with SYMPK in spermatogenic cells (Figure 5C). Collectively, these results suggest a role of SYMPK regulating pre-mRNA splicing in spermatogenic cells.
Figure 5. SYMPK interacts with DDX5 and PRPF8 in spermatogenic cells. (A,B) Localization of DDX5 (A) and PRPF8 (B) in P16 and adult wild-type testes. DNA was stained with DAPI. Scale bar, 50 μm. (C) Co-immunoprecipitation using the anti-SYMPK antibody or IgG confirmed that SYMPK interacts with DDX5 and PRPF8 in spermatogenic cells.
SYMPK Modulates Pre-mRNA Splicing in Spermatogenic Cells
To investigate the molecular consequences of Sympk deficiency in germ cells, whole-transcriptome RNA sequencing (RNA-Seq) analysis was performed using total RNA extracted from wt and Sympk cKOStra8–Cre spermatogenic cells. With a padjust < 0.01, a total of 6,528 transcripts showed a more than eightfold differential expression in SYMPK-deficient spermatogenic cells: within which, 2,651 genes were upregulated and 3,877 genes were downregulated (Figure 6A). Gene Ontology (GO) analysis identified that the spermatogenesis was most significantly affected (Figure 6B). Interestingly, only 10 meiotic genes were upregulated, while 72 genes associated with meiosis were downregulated. Reverse transcription quantitative PCR (RT-qPCR) results confirmed that six genes required for spermatogenesis were downregulated (Figure 6C). The dysregulated expressions of meiosis-specific genes may have contributed to the meiotic defects in SYMPK-deficient male germ cells.
Figure 6. SYMPK is involved in transcript splicing during spermatogenesis. (A) Volcano plot of the differentially expressed transcripts in Sympk cKOStra8–Cre spermatogenic cells compared with the wild-type (wt) controls. Green dots represent significantly downregulated transcripts, red dots represent significantly upregulated transcripts (Q value < 0.05, fold change of RPKM > 2), and gray dots represent unchanged transcripts. (B) Gene Ontology (GO) term enrichment analysis of the significantly affected transcripts. (C) Validation of the differentially expressed genes by real-time PCR analysis. (D) Summary of five significantly affected alternative splicing (AS) events in Sympk cKOStra8–Cre spermatogenic cells at P18. (E) RT-PCR verification of the AS of transcripts in wt and Sympk cKOStra8–Cre spermatogenic cells. RT-PCR was performed with specific primers (Supplementary Table 1). White arrow stands for unspecific band. (F) Western blotting analysis of the expressions of Sympk and Sun1 in wt and Sympk cKOStra8–Cre spermatogenic cells, with GAPDH as the loading control. The solid triangle stands for unspecific band.
To dissect the impacts of Sympk deletion on AS, the types of AS between the control and Sympk cKO spermatogenic cells were compared based on the reads on target and junction counts using the rMATS software. Compared with the control, 6,046 AS events were significantly affected (p < 0.01) in Sympk cKOStra8–Cre spermatogenic cells. Among the affected AS events, the majority of the changed splicing events were skipped exons (Figure 6D). Exon skipping is the most enriched AS form during mouse spermatogenesis (Schmid et al., 2013; Margolin et al., 2014). Moreover, the SYMPK-binding protein PRPF8 is a core component of spliceosomal complexes, which indicated that SYMPK participated in the AS regulation unbiasedly.
To validate whether AS is indeed disturbed due to SYMPK deficiency, four transcripts with alterations in the splicing pattern identified by rMATS were examined by semi-quantitative RT-PCR using specific primers (Supplementary Table 1), namely, Sun1, Brdt, Meioc, and Ranbp9. The predicted aberrant splicing patterns of these transcripts were successfully verified in the complementary DNA (cDNA) of Sympk cKOStra8–Cre spermatogenic cells (Figure 6E). These data demonstrated that SYMPK was involved in mRNA splicing during spermatogenesis.
Depletion of Sympk Results in Decreases in SUN1 Protein
SUN1 is an inner nuclear membrane protein associated with telomeres during meiotic prophase I. Disruption of Sun1 in mice impaired the efficient homolog pairing, synapsis formation, and recombination in meiosis (Ding et al., 2007). Interestingly, the AS pattern of Sun1 is dramatically changed in Sympk-deficient spermatogenic cells (Figure 6E). The similar phenotype between Sympk cKOStra8–Cre and Sun1 null mice promoted us to analyze the expression of SUN1 protein in Sympk cKOStra8–Cre spermatogenic cells. Compared with the control, the expression of Sun1 was reduced dramatically in Sympk cKOStra8–Cre spermatogenic cells (Figure 6F). Thus, these results suggest that SYMPK deletion possibly decreased Sun1 expression by changing its pre-mRNA splicing, subsequently leading to the meiotic defects.
Discussion
Here, we report that SYMPK is essential for meiosis and male fertility. Although the deletion of Sympk in either embryonic or postnatal stage leads to infertility in male mice, development of the testes from mice with Sympk deletion at the embryonic and postnatal stages was different. In Sympk cKODdx4–Cre male mice, the number of germ cells was reduced at P4 and disappeared at P18 in the testes. In Sympk cKOStra8–Cre tubules, we did not observe any reduction of spermatogonia, while the spermatocyte number was sharply reduced. Furthermore, Sympk cKOStra8–Cre spermatocytes displayed defects in meiosis progress, including chromosome asynapsis, DSB repair failure, defective meiotic recombination, and reduced crossover formation. Consistently, BRCA1 was localized to the unsynapsed chromosomes of Sympk cKOStra8–Cre spermatocytes at pachytene, not restricted to the sex chromosomes, which is different from that in wt spermatocytes. Considering the role of BRCA1 in recruiting the kinase ATR to phosphorylate H2AX on unsynapsed chromosomes and in meiotic sex chromosome inactivation (MSCI) establishment (Broering et al., 2014), the abnormal BRCA1 localization and defective meiotic DSB repair may have resulted in failure of meiotic silencing, finally causing the altered transcriptional profile and apoptosis of spermatocytes.
AS is the major posttranslational modification that is prevalent in the male germ cells and is particularly active in late pachytene spermatocytes and spermatids. Any mutation affecting AS would be harmful to successful spermatogenesis (Venables, 2002). Although SYMPK is not an RNA-binding protein, SYMPK and CPSF functioned as cofactors of two splicing regulators (RBFOX2 and NOVA2) to regulate AS in somatic cells. We wondered whether SYMPK would also participate in the AS regulation of germ cells. Here, we identified two SYMPK-binding partners (DDX5 and PRPF8) in spermatogenic cells through IP-MS. Similar to the localization pattern of SYMPK in the testes, both DDX5 and PRPF8 were localized in the nucleus of spermatogenic cells. In somatic cells, DDX5 coordinated with hnRNA1 to regulate alternative pre-mRNA splicing (Lee et al., 2018). Recently, it has been reported that DDX5 is required for the splicing of critical genes for spermatogenesis in spermatogonia (Legrand et al., 2019). PRPF8 plays a critical role in pre-mRNA splicing as the core component of spliceosomal complexes. In addition, PRPF8 also mediates the assembly of several spliceosomal proteins. It is reported that PRPF8 mutation caused aberrant splicing in some human diseases, such as myeloid malignancies and autosomal-dominant retinitis pigmentosa (Kurtovic-Kozaric et al., 2015; Xiao et al., 2020). Therefore, SYMPK is implicated in pre-mRNA splicing in spermatogenic cells.
The RNA-Seq results showed that Sympk deletion affected the splicing patterns of thousands of genes in spermatogenic cells, many of which have critical functions during spermatogenesis. As one of the top 10 most changed meiotic genes for the AS pattern, Sun1 is a component of LINC complexes that mediates nuclear envelop attachment of meiotic telomeres and is also essential for driving chromosome synapsis and recombination (Scherthan et al., 1996; Ding et al., 2007; Chi et al., 2009; Koszul and Kleckner, 2009). BRDT, a testis-specific chromatin protein, specifically binds to acetylated histones and plays a key role in spermatogenesis (Pivot-Pajot et al., 2003; Manterola et al., 2018). Meioc is a conserved germ cell-specific gene expressed during male meiotic prophase I. MEIOC promotes the meiotic cell cycle program in coordination with YTHDC2 (Soh et al., 2017). The above genes were proven to be spliced alternatively in Sympk cKO spermatogenic cells. RANBP9 is a multifunctional protein in somatic cells and plays a novel role in regulating splicing in spermatogenic cells (Bao et al., 2014). Here, the splicing pattern of Ranbp9 was changed and was verified by RT-PCR, indicating that the AS defects of many critical genes for germ cell development possibly resulted from the abnormal splicing of AS regulators, such as Ranbp9. In addition, the expression of Sun1 was significantly reduced in Sympk cKO spermatogenic cells. Considering the phenotype of Sun1–/– spermatocytes and the significance of Sun1 in meiosis, we speculated that the meiotic defects of Sympk-deficient spermatocytes may be from the partial loss of SUN1. Additionally, 10 genes were upregulated and another 72 genes were downregulated in meiosis in the absence of SYMPK, but we do not know whether the phenotype was resulted by one or several of these misregulated genes.
In summary, our study demonstrates the requirement of SYMPK for meiosis and fertility in male mice and defines the role of SYMPK in the AS of numerous mRNAs required for normal spermatogenesis. However, more molecular details need to be delineated in the future, such as the role of SYMPK in the nuclear and cytoplasm polyadenylation of mRNAs in germ cells.
Materials and Methods
Animals
All mice were maintained on a C57BL/6-ICR mixed background and housed in the pathogen-free animal facility of Wuhan University. All animal experiments were conducted in accordance with the animal protocols approved by the Institutional Animal Care and Use Committee of Wuhan University. SympkF/+ mice were purchased from Wellcome Trust Sanger Institute in London. Ddx4-Cre transgenic mice were provided by Dr. Xiaoyan Huang from Nanjing Medical University. Stra8-Cre transgenic mice were kindly provided by Dr. Minghan Tong from the State Key Laboratory of Molecular Biology in Shanghai.
All mice were genotyped by tail DNA extraction followed by gene-specific PCR using the specific primers (Supplementary Table 1).
Antibody Generation
To generate a polyclonal antibody against SYCP3, full-length SYCP3 fused with His-tag was cloned into the pET42-b vector and expressed in Escherichia coli. Recombinant SYCP3 was affinity purified with Ni-NTA resin and used to immunize rabbits and mouse. The anti-SYCP3 sera were stored at -80°C until use. Anti-SYCP1 (aa871–946), anti-DDX4 (aa541–728), anti-MLH1 (aa528–737), and anti-HORMAD1 (aa2–277) sera were produced in the same way. The primers used for the construction of recombinant expression plasmids are listed in Supplementary Table 1.
Histological Analyses, Immunostaining, and Imaging
For histological evaluation, testes from the wt control and Sympk cKO mice were isolated and fixed in Bouin’s solution overnight at room temperature, embedded with paraffin, and sectioned at 5–8 μm. After dewaxing and hydration, the sections were stained with hematoxylin and eosin.
For immunostaining, the samples were fixed in 4% paraformaldehyde (PFA) overnight at 4°C, dehydrated, embedded, and then sectioned using Cryostat Microtome (Leica CM1950, Heidelberg, Germany). TUNEL assays were performed using the In Situ Cell Death Detection Kit (Roche, Indianapolis, IN, United States). Nuclear spread analysis of the spermatocytes was performed as previously described (Luo et al., 2013). The primary antibodies used in this study are listed in Supplementary Table 2. Dylight 488- or Dylight 594-conjugated secondary antibody (Proteintech, Rosemont, Il, United States) was used at 1:100 dilutions, respectively. Histological and immunostaining images were captured with the Axio Imager 2 microscope (Zeiss, Oberchoken, Germany).
Enrichment of Spermatogenic Cells
Spermatogenic cells were enriched using a two-step enzymatic digestion process followed by a differential adhesion method as previously described, with some modifications (Liu et al., 2017). Briefly, the testes were decapsulated, then the seminiferous tubules were transferred into 10 ml Krebs buffer with 500 μl 10 mg/ml collagenase, and incubated at 37°C, 120 rpm, for 10 min with gentle shaking every 3–5 min to accelerate testis dissociation.
Then, the cell suspension was centrifuged at 600 × g for 5 min and the pellet was digested in 10 ml Krebs buffer with 30 mg trypsin and 3 μg DNase I (preventing cells from clumping) and incubated at 37°C with shaking at 120 rpm for 10 min to dissociate the seminiferous tubules into single cells. The suspension was neutralized with 5 ml Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and filtered through a 100-μm mesh cell strainer. After centrifuging at 600 × g for 5 min, the cell pellet was suspended in 10 ml of the ES medium and seeded in a 10-cm culture dish. After 4–6 h of short-term incubation at 37°C, the floating and weakly adhering cells were collected and identified using Western blotting against PLZF, SYCP1, SYCP3, and SOX9.
Co-immunoprecipitation Followed by Mass Spectrometry and Western Blotting
Co-immunoprecipitation was performed with the spermatogenetic cells of P16 testes from wt and Sympk cKOstra8–Cre mice using the anti-SYMPK antibody. Briefly, the spermatogenetic cells were homogenized in 1 ml lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 1 mM DTT) with 1 × cocktail (Roche) as a proteinase inhibitor. The lysates were treated with 0.5 mg/ml RNase A and 500 U/ml DNase at room temperature for 1 h, then pre-cleared with protein A agarose beads for 2 h at 4°C. Afterward, the anti-SYMPK antibody was added into the sample and incubated on an orbital shaker overnight at 4°C, followed by incubating with protein A agarose beads for 4 h at 4°C. The protein–beads complex was washed with lysis buffer three times.
For mass spectrometry, the purified protein–beads complex, shipped in solidified carbon dioxide, was subjected to HPLC followed by high-resolution mass spectrometry (HRMS) at the National Facility for Protein Science in Shanghai (NFPS), Zhangjiang Lab, China.
For Western blotting, the pre-cleared samples from the spermatogenetic cells of P16 testes from wt mice were divided into two parts and incubated with the anti-SYMPK antibody and immunoglobulin G (IgG) overnight at 4°C. The following steps were the same as those in the previous description. The protein–beads complex was boiled in 1 × sodium dodecyl sulfate (SDS) loading buffer for 10 min. After centrifuging at 1,2000 × g for 10min at 4°C, the supernatant was directly used for Western blotting analysis.
Western Blotting
Protein samples were prepared using RIPA lysis buffer (20mM Tris, pH8, 150mM NaCl, 1% NP-40, 0.1% sodium deoxycholate, 1mM DTT, and 2mM EDTA, 100 μg/ml) with 1 × protease inhibitor cocktail (Roche). Then, the protein samples were separated in a 10% SDS-PAGE gel and transferred onto polyvinylidene difluoride (PVDF) membranes. After blocking with 5% non-fat milk for 1 h at room temperature, the membranes were incubated with diluted primary antibodies at 4°C overnight. After three washes with TBST (Tris-buffered saline/Tween 20), the membranes were incubated with secondary antibodies conjugated with horseradish peroxidase (AS014; ABclonal, Woburn, MA, United States) at room temperature for 1 h. The signals were developed with the SuperSignalTM West Pico PLUS Chemiluminescent Substrate (#34577; ThermoFisher, Waltham, MA, United States), detected with Amersham Imager 600 (GE Healthcare Life Sciences, Marlborough, MA, United States). Information on the primary antibodies is listed in Supplementary Table 2.
RNA Extraction and RT-qPCR
Total RNA was extracted from the spermatogenic cells of wt or Sympk cKO mice using the RNAprep Pure Micro Kit (TIANGEN, Beijing, China). Then, 2.5 μg of total RNA from each sample was subjected to reverse transcription into first-strand cDNA using the RevertAid RT Reverse Transcription Kit (K1691; ThermoFisher). For qPCR reaction, 140 ng cDNA was loaded as template in every 20 μl reaction volume for each sample. Real-time RT-PCR was performed using FastStart Essential DNA Green Master (06402712001; Roche) on a CFX Connect Real-Time PCR Detection System (Bio-Rad, Hercules, CA, United States). Relative gene expression was analyzed based on the 2–△△Ct method with Gapdh as the internal control.
The primers used to determine the number of target genes were designed in PubMed combined with the Primer Premier 5.0 software. Primer information is listed in Supplementary Table 1.
RNA Sequencing
Spermatogenic cells were prepared from 18-day-old control and Sympk cKOStra8–Cre mice. Total RNA was extracted using the RNAprep Pure Cell/Bacteria Kit (TIANGEN) according to the manufacturer’s protocol. Then, RNA quality was determined with the 2100 Bioanalyzer (Agilent, Palo Alto, CA, United States) and quantified using the ND-2000 (NanoDrop Technologies, Wilmington, DE, United States). Only high-quality RNA samples (OD260/OD280 = 1.8–2.2, OD260/OD230 ≥ 2.0, RIN ≥ 7.5, 28S:18S ≥ 1.0) were used to construct the sequencing library.
The RNA-Seq transcriptome library was prepared following the TruSeqTM RNA sample preparation kit from Illumina (San Diego, CA, United States) using 5 μg of total RNA. Shortly, the mRNA was isolated according to the polyA selection method by oligo(dT) beads and then firstly fragmented by a fragmentation buffer. Secondly, double-strand cDNA was synthesized using a SuperScript double-stranded cDNA synthesis kit (Invitrogen, Carlsbad, CA, United States) with random hexamer primers (Illumina). Then, the synthesized cDNA was subjected to end repair, phosphorylation, and “A” base addition according to Illumina’s library construction protocol. The libraries were size selected for cDNA target fragments of 200–300 bp on 2% Low Range Ultra Agarose followed by PCR amplification using Phusion DNA polymerase (NEB, Ipswich, MA, United States) for 15 PCR cycles. After quantification by TBS380, the paired-end RNA-Seq library was sequenced with the Illumina HiSeq xten (read length, 2 × 150 bp).
Bioinformatics Analysis
The raw paired-end reads were trimmed and quality controlled using SeqPrep1 and Sickle2, with default parameters. Then, the clean reads were separately aligned to the reference genome with orientation mode using TopHat3 software.
To identify the differentially expressed genes (DEGs) between two different samples, the expression level of each transcript was calculated according to the fragments per kilobase of exon per million mapped reads (FRKM) method. RSEM4 was used to quantify gene abundances. The R statistical package software EdgeR (Empirical analysis of Digital Gene Expression in R)5 was utilized for analysis of differential expression. GO functional enrichment analysis was carried out by Goatools6. All the alternative splice events that occurred in our sample were identified using replicate multivariate analysis of transcript splicing (rMATS)7. Analysis of differential expression splicing (DES) was also performed using rMATS software.
Statistics
Statistical analysis was performed using GraphPad Prism 5 software. The results of the statistical analyses were subjected to a Student’s t-test: ∗∗∗p < 0.001. The values were presented as the mean ± SD.
Data Availability Statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.
Ethics Statement
The animal study was reviewed and approved by Wuhan University.
Author Contributions
ML and RW designed the project. RW and JZ performed most of the experiments. BZ and XH offered the mouse and analyzed phenotypes. XZ, ZC, JL, CL, and RL analyzed the data and phenotypes. All authors participated in the manuscript preparation and approved the final manuscript.
Funding
This work is supported by the National Key Research & Development Program of China (2018YFC1003400), National Natural Science Foundation of China (31771588), and the Thousand Youth Talents Plan to ML.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
We are grateful to Minghan Tong for providing Stra8-Cre mice.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2021.715733/full#supplementary-material
Supplementary Figure 1 | SYMPK is absent in germ cells of Sympk cKO mice. Immunostaining of SYMPK in the testes of wt control and Sympk cKO mice at P4 (A) and P13 (B). Scale bar, 50 μm.
Supplementary Figure 2 | Phenotype of male mice with Sympk deficiency at embryonic stage by Ddx4-Cre. (A) Morphological analysis of testes from adult wt and Sympk cKODdx4–Cre mice. (B) Histology of Sympk cKODdx4–Cre testes at P10 and P16. Scale bar, 50 μm. (C) Histology of testes and cauda epididymidis from adult Sympk cKODdx4–Cre male mice. Scale bar, 100 μm.
Supplementary Figure 3 | SYMPK is required for the survival of spermatogonia and spermatocytes. (A) Immunostaining of PLZF in control and Sympk cKOStra8–Cre testes at P13. Scale bar, 50 μm. (B) Quantification of PLZF positive cells per seminiferous tubules in control and Sympk cKOStra8–Cre testes at P13 (n = 30 for control group, n = 69 for Sympk cKOStra8–Cre group). (C) Immunostaining of SYCP3 in control and Sympk cKOStra8–Cre testes at P13. Scale bar, 50 μm. (D) The number of SYCP3 positive cells in each Sympk cKOStra8–Cre tubule which containing SYCP3 positive cell and control tubule were counted, and compared between two groups. (n = 20 for both control group Sympk cKOStra8–Cre group). (E) Immunostaining of DDX4 in wt control and Sympk cKODdx4–Cre testes at P4. Scale bar, 100 μm. (F) The number of DDX4 positive cells per seminiferous tubules in control and Sympk cKODdx4–Cre tests at P4. At least 100 tubules were counted from two mice for each immunostaining assay. (G) Immunostaining of DDX4 in control, Sympk cKODdx4–Cre and Sympk cKOStra8–Cre testes at P18. Scale bar, 50 μm. All sections were stained with DAPI to label nucleus.
Supplementary Figure 4 | The localization of BRCA1 in Sympk cKOStra8–Cre spermatocytes. Immunostaining of meiotic chromosome spreads using the antibody against BRCA1. Scale bar, 20 μm.
Supplementary Figure 5 | Sympk cKOStra8–Cre spermatocytes show reduced crossover formation. (A) Immunostaining for SYCP3 (red) and MLH1 (green) in control and Sympk cKOStra8–Cre spermatocytes. (B) Quantification of average MLH1 foci per spermatocyte. Sympk-deficient spermatocytes possess significantly fewer total MLH1 foci than wild-type spermatocyte (n = 17 for wt, n = 11for Sympk cKO). Scale bar, 20 μm.
Supplementary Figure 6 | Identification of the enriched spermatogenic cells from testes by western blotting. Protein extracts from testes and enriched spermatogenic cells were analyzed by western blotting, using antibodies against PLZF, SYCP1, SYCP3, SOX9. PLZF are marker for spematogonia, SYCP1 and SYCP3 are markers for spermatocyte, SOX9 is a marker for Sertoli cell (Gao et al., 2006), and GAPDH was used as the loading control.
Footnotes
- ^ https://github.com/jstjohn/SeqPrep
- ^ https://github.com/najoshi/sickle
- ^ http://tophat.cbcb.umd.edu/, version2.0.0.
- ^ http://deweylab.biostat.wisc.edu/rsem/
- ^ http://www.bioconductor.org/packages/2.12/bioc/html/edgeR.html
- ^ https://github.com/tanghaibao/Goatools
- ^ http://rnaseq-mats.sourceforge.net/
References
Anderson, L. K., Reeves, A., Webb, L. M., and Ashley, T. (1999). Distribution of crossing over on mouse synaptonemal complexes using immunofluorescent localization of MLH1 protein. Genetics 151, 1569–1579. doi: 10.1093/genetics/151.4.1569
Bao, J., Tang, C., Li, J., Zhang, Y., Bhetwal, B. P., Zheng, H., et al. (2014). RAN-binding protein 9 is involved in alternative splicing and is critical for male germ cell development and male fertility. PLoS Genet. 10:e1004825. doi: 10.1371/journal.pgen.1004825
Barnard, D. C., Ryan, K., Manley, J. L., and Richter, J. D. (2004). Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation. Cell 119, 641–651. doi: 10.1016/j.cell.2004.10.029
Bellani, M. A., Romanienko, P. J., Cairatti, D. A., and Camerini-Otero, R. D. (2005). SPO11 is required for sex-body formation, and Spo11 heterozygosity rescues the prophase arrest of Atm-/- spermatocytes. J. Cell Sci. 118, 3233–3245. doi: 10.1242/jcs.02466
Broering, T. J., Alavattam, K. G., Sadreyev, R. I., Ichijima, Y., Kato, Y., Hasegawa, K., et al. (2014). BRCA1 establishes DNA damage signaling and pericentric heterochromatin of the X chromosome in male meiosis. J. Cell Biol. 205, 663–675. doi: 10.1083/jcb.201311050
Brown, M. S., and Bishop, D. K. (2014). DNA strand exchange and RecA homologs in meiosis. Cold Spring Harb. Perspect. Biol. 7:a016659. doi: 10.1101/cshperspect.a016659
Cappell, K. M., Larson, B., Sciaky, N., and Whitehurst, A. W. (2010). Symplekin specifies mitotic fidelity by supporting microtubule dynamics. Mol. Cell Biol. 30, 5135–5144. doi: 10.1128/mcb.00758-10
Chen, Y., Zheng, Y., Gao, Y., Lin, Z., Yang, S., Wang, T., et al. (2018). Single-cell RNA-seq uncovers dynamic processes and critical regulators in mouse spermatogenesis. Cell Res. 28, 879–896. doi: 10.1038/s41422-018-0074-y
Chi, Y. H., Cheng, L. I., Myers, T., Ward, J. M., Williams, E., Su, Q., et al. (2009). Requirement for Sun1 in the expression of meiotic reproductive genes and piRNA. Development 136, 965–973. doi: 10.1242/dev.029868
de Vries, F. A., de Boer, E., van den Bosch, M., Baarends, W. M., Ooms, M., Yuan, L., et al. (2005). Mouse Sycp1 functions in synaptonemal complex assembly, meiotic recombination, and XY body formation. Genes Dev. 19, 1376–1389. doi: 10.1101/gad.329705
Ding, X., Xu, R., Yu, J., Xu, T., Zhuang, Y., and Han, M. (2007). SUN1 is required for telomere attachment to nuclear envelope and gametogenesis in mice. Dev. Cell 12, 863–872. doi: 10.1016/j.devcel.2007.03.018
Elliott, D. J., and Grellscheid, S. N. (2006). Alternative RNA splicing regulation in the testis. Reproduction 132, 811–819. doi: 10.1530/rep-06-0147
Fukuda, T., Daniel, K., Wojtasz, L., Toth, A., and Hoog, C. (2010). A novel mammalian HORMA domain-containing protein, HORMAD1, preferentially associates with unsynapsed meiotic chromosomes. Exp. Cell Res. 316, 158–171. doi: 10.1016/j.yexcr.2009.08.007
Gallardo, T., Shirley, L., John, G. B., and Castrillon, D. H. (2007). Generation of a germ cell-specific mouse transgenic Cre line, Vasa-Cre. Genesis 45, 413–417. doi: 10.1002/dvg.20310
Gao, F., Maiti, S., Alam, N., Zhang, Z., Deng, J. M., Behringer, R. R., et al. (2006). The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis. Proc. Natl. Acad. Sci. U. S. A. 103, 11987–11992. doi: 10.1073/pnas.0600994103
Goldstrohm, A. C., and Wickens, M. (2008). Multifunctional deadenylase complexes diversify mRNA control. Nat. Rev. Mol. Cell Biol. 9, 337–344. doi: 10.1038/nrm2370
Griswold, M. D. (2016). Spermatogenesis: the Commitment to Meiosis. Physiol. Rev. 96, 1–17. doi: 10.1152/physrev.00013.2015
Hannigan, M. M., Zagore, L. L., and Licatalosi, D. D. (2017). Ptbp2 Controls an Alternative Splicing Network Required for Cell Communication during Spermatogenesis. Cell Rep. 19, 2598–2612. doi: 10.1016/j.celrep.2017.05.089
Hofmann, I., Schnolzer, M., Kaufmann, I., and Franke, W. W. (2002). Symplekin, a constitutive protein of karyo- and cytoplasmic particles involved in mRNA biogenesis in Xenopus laevis oocytes. Mol. Biol. Cell 13, 1665–1676. doi: 10.1091/mbc.01-12-0567
Kan, Z., Garrett-Engele, P. W., Johnson, J. M., and Castle, J. C. (2005). Evolutionarily conserved and diverged alternative splicing events show different expression and functional profiles. Nucleic Acids Res. 33, 5659–5666. doi: 10.1093/nar/gki834
Kashiwabara, S., Noguchi, J., Zhuang, T., Ohmura, K., Honda, A., Sugiura, S., et al. (2002). Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP. Science 298, 1999–2002. doi: 10.1126/science.1074632
Kasowitz, S. D., Ma, J., Anderson, S. J., Leu, N. A., Xu, Y., Gregory, B. D., et al. (2018). Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 14:e1007412. doi: 10.1371/journal.pgen.1007412
Keon, B. H., Schafer, S., Kuhn, C., Grund, C., and Franke, W. W. (1996). Symplekin, a novel type of tight junction plaque protein. J. Cell Biol. 134, 1003–1018. doi: 10.1083/jcb.134.4.1003
Kogo, H., Tsutsumi, M., Ohye, T., Inagaki, H., Abe, T., and Kurahashi, H. (2012). HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes. Genes Cells 17, 439–454. doi: 10.1111/j.1365-2443.2012.01600.x
Koszul, R., and Kleckner, N. (2009). Dynamic chromosome movements during meiosis: a way to eliminate unwanted connections?. Trends Cell Biol. 19, 716–724. doi: 10.1016/j.tcb.2009.09.007
Kurtovic-Kozaric, A., Przychodzen, B., Singh, J., Konarska, M. M., Clemente, M. J., Otrock, Z. K., et al. (2015). PRPF8 defects cause missplicing in myeloid malignancies. Leukemia 29, 126–136. doi: 10.1038/leu.2014.144
Lascarez-Lagunas, L., Martinez-Garcia, M., and Colaiacovo, M. (2020). SnapShot: meiosis - Prophase I. Cell 181, 1442–1442.e1.
Lee, Y. J., Wang, Q., and Rio, D. C. (2018). Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5. Genes Dev. 32, 1060–1074. doi: 10.1101/gad.316034.118
Legrand, J. M. D., Chan, A. L., La, H. M., Rossello, F. J., Anko, M. L., Fuller-Pace, F. V., et al. (2019). DDX5 plays essential transcriptional and post-transcriptional roles in the maintenance and function of spermatogonia. Nat. Commun. 10:2278.
Liu, W., Wang, F., Xu, Q., Shi, J., Zhang, X., Lu, X., et al. (2017). BCAS2 is involved in alternative mRNA splicing in spermatogonia and the transition to meiosis. Nat. Commun. 8:14182.
Luo, M., Yang, F., Leu, N. A., Landaiche, J., Handel, M. A., Benavente, R., et al. (2013). MEIOB exhibits single-stranded DNA-binding and exonuclease activities and is essential for meiotic recombination. Nat. Commun. 4: 2788.
Manterola, M., Brown, T. M., Oh, M. Y., Garyn, C., Gonzalez, B. J., and Wolgemuth, D. J. (2018). BRDT is an essential epigenetic regulator for proper chromatin organization, silencing of sex chromosomes and crossover formation in male meiosis. PLoS Genet. 14:e1007209. doi: 10.1371/journal.pgen.1007209
Margolin, G., Khil, P. P., Kim, J., Bellani, M. A., and Camerini-Otero, R. D. (2014). Integrated transcriptome analysis of mouse spermatogenesis. BMC Genomics 15:39. doi: 10.1186/1471-2164-15-39
Misra, A., Ou, J., Zhu, L. J., and Green, M. R. (2015). Global Promotion of Alternative Internal Exon Usage by mRNA 3’ End Formation Factors. Mol. Cell 58, 819–831. doi: 10.1016/j.molcel.2015.03.016
O’Bryan, M. K., Clark, B. J., McLaughlin, E. A., D’Sylva, R. J., O’Donnell, L., Wilce, J. A., et al. (2013). RBM5 is a male germ cell splicing factor and is required for spermatid differentiation and male fertility. PLoS Genet. 9:e1003628. doi: 10.1371/journal.pgen.1003628
Pivot-Pajot, C., Caron, C., Govin, J., Vion, A., Rousseaux, S., and Khochbin, S. (2003). Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. Mol. Cell Biol. 23, 5354–5365.
Ribeiro, J., Abby, E., Livera, G., and Martini, E. (2016). RPA homologs and ssDNA processing during meiotic recombination. Chromosoma 125, 265–276. doi: 10.1007/s00412-015-0552-7
Sadate-Ngatchou, P. I., Payne, C. J., Dearth, A. T., and Braun, R. E. (2008). Cre recombinase activity specific to postnatal, premeiotic male germ cells in transgenic mice. Genesis 46, 738–742. doi: 10.1002/dvg.20437
Scherthan, H., Weich, S., Schwegler, H., Heyting, C., Harle, M., and Cremer, T. (1996). Centromere and telomere movements during early meiotic prophase of mouse and man are associated with the onset of chromosome pairing. J. Cell Biol. 134, 1109–1125. doi: 10.1083/jcb.134.5.1109
Schmid, R., Grellscheid, S. N., Ehrmann, I., Dalgliesh, C., Danilenko, M., Paronetto, M. P., et al. (2013). The splicing landscape is globally reprogrammed during male meiosis. Nucleic Acids Res. 41, 10170–10184. doi: 10.1093/nar/gkt811
Soh, Y. Q. S., Mikedis, M. M., Kojima, M., Godfrey, A. K., de Rooij, D. G., and Page, D. C. (2017). Meioc maintains an extended meiotic prophase I in mice. PLoS Genet. 13:e1006704. doi: 10.1371/journal.pgen.1006704
Takagaki, Y., and Manley, J. L. (2000). Complex protein interactions within the human polyadenylation machinery identify a novel component. Mol. Cell Biol. 20, 1515–1525. doi: 10.1128/mcb.20.5.1515-1525.2000
Turner, J. M., Aprelikova, O., Xu, X., Wang, R., Kim, S., Chandramouli, G. V., et al. (2004). BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation. Curr. Biol. 14, 2135–2142. doi: 10.1016/j.cub.2004.11.032
Venables, J. P. (2002). Alternative splicing in the testes. Curr. Opin. Genet. Dev. 12, 615–619. doi: 10.1016/s0959-437x(02)00347-7
Weill, L., Belloc, E., Bava, F. A., and Mendez, R. (2012). Translational control by changes in poly(A) tail length: recycling mRNAs. Nat. Struct. Mol. Biol. 19, 577–585. doi: 10.1038/nsmb.2311
Xiao, T., Xie, Y., Zhang, X., Xu, K., Zhang, X., Jin, Z. B., et al. (2020). Variant Profiling of a Large Cohort of 138 Chinese Families With Autosomal Dominant Retinitis Pigmentosa. Front. Cell Dev. Biol. 8:629994. doi: 10.3389/fcell.2020.629994
Xing, H., Mayhew, C. N., Cullen, K. E., Park-Sarge, O. K., and Sarge, K. D. (2004). HSF1 modulation of Hsp70 mRNA polyadenylation via interaction with symplekin. J. Biol. Chem. 279, 10551–10555. doi: 10.1074/jbc.m311719200
Xu, X., Aprelikova, O., Moens, P., Deng, C. X., and Furth, P. A. (2003). Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice. Development 130, 2001–2012. doi: 10.1242/dev.00410
Yeo, G., Holste, D., Kreiman, G., and Burge, C. B. (2004). Variation in alternative splicing across human tissues. Genome Biol. 5:R74.
Yu, J., Lu, W., Ge, T., Huang, R., Chen, B., Ye, M., et al. (2019). Interaction Between Sympk and Oct4 Promotes Mouse Embryonic Stem Cell Proliferation. Stem Cells 37, 743–753. doi: 10.1002/stem.2992
Keywords: meiosis, SYMPK, alternative splicing, spermatocytes, meiotic recombination
Citation: Wu R, Zhan J, Zheng B, Chen Z, Li J, Li C, Liu R, Zhang X, Huang X and Luo M (2021) SYMPK Is Required for Meiosis and Involved in Alternative Splicing in Male Germ Cells. Front. Cell Dev. Biol. 9:715733. doi: 10.3389/fcell.2021.715733
Received: 27 May 2021; Accepted: 12 July 2021;
Published: 09 August 2021.
Edited by:
Zhao-Jia Ge, Qingdao Agricultural University, ChinaReviewed by:
Shunfeng Cheng, Qingdao Agricultural University, ChinaPing Ye, Avera Research Institute Center for Pediatric and Community Research, United States
Darpan Medhi, Memorial Sloan Kettering Cancer Center, United States
Copyright © 2021 Wu, Zhan, Zheng, Chen, Li, Li, Liu, Zhang, Huang and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mengcheng Luo, bHVvbWVuZ2NoZW5nQHdodS5lZHUuY24=; Xiaoyan Huang, YmJoeHlAbmptdS5lZHUuY24=; Xinhua Zhang, emhhbmd4aW5odWFkQDE2My5jb20=
†These authors have contributed equally to this work